期刊文献+

28例肝内胆管细胞癌手术治疗分析

Analysis of operative treatment of patients with cholangiocarcinoma
下载PDF
导出
摘要 目的提高肝内胆管细胞癌的诊断和治疗水平,分析其临床特点及预后相关因素。方法回顾性分析中国医学科学院肿瘤医院1970至2005年外科治疗的28例肝内胆管细胞癌患者的临床资料。结果28例患者中AFP阳性率为10.7%(3/28),肝硬化阳性率25.0%(7/28)。根治性切除组1,3,5年生存率分别为82.3%、45.8%和45.8%;姑息性切除组1,3年生存率分别为11.1%和0。结论肝内胆管细胞癌以手术治疗为主。根治性手术切除是获得长期生存的惟一途径。 Objective To improve the diagnosis and treatment of the cholangiocarcinoma and analyze the clinical characteristics and the prognosis. Method Twenty-eight cases of the cholangiocarcinoma from 1970 to 2005 were analyzed retrospectively. Results In 28 cases, the positive rates of AFP and liver cirrhosis were 10.7% and 25.0% respectively. The 1-,3-,5-year survival rate were 82.3% ,45.8% and 45.8% in the patients with radical operation and 11.1% ,0 in those with non-radical operation. Conclusion Operation is the effective treatment for the cholangiocarcinoma. Radical operation is the only way for obtaining long-term survival.
出处 《中国肿瘤临床与康复》 2006年第5期431-433,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肝内胆管细胞癌/外科学 Cholangiocarcinoma/surgery
  • 相关文献

参考文献1

二级参考文献37

  • 1[1]Chen MF.Peripheral cholangiocarcinoma (cholangiocellular carcinoma):Clinical features,diagnosis and treatment.J Gastroenterol Hepatol 1999; 14:1144-1149
  • 2[2]Liver Cancer Study Group of Japan.Classification of primary liver cancer,Kanehara,Tokyo (1997) 1st English ed.
  • 3[3]Suzuki H,Isaji S,Pairojkul C,Uttaravichien T.Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.J Hepatobiliary Pancreat Surg 2000; 7:206-211
  • 4[4]Sirica AE,Gainey TW,Harrell MB,Caran N.Cholangiocarcinogenesis and biliary adaptation responses in hepatic injury.In:Sirica AE,Longnecker DS,eds.Biliary and Pancreatic Ductal Epithelia-Pathobiology and Pathophysiology New York:Marcel Dekker 1997:229-290
  • 5[5]Chapman RW.Risk factors for biliary tract carcinogenesis.Ann Oncol 1999; 10(Suppl 4):S308-S311
  • 6[6]Chu KM,Lo CM,Liu CL,Fan ST.Malignancy associated with hepatolithiasis.Hepatogastroenterology 1997; 44:352-357
  • 7[7]Su WC,Shiesh SC,Liu HS,Chen CY,Chow NH,Lin XZ.Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF,TGF-β,and PDGF in bile from biliary malignancies and inflammatory disorders.Dig Dis Sci 2001; 46:1387-1392
  • 8[8]Chen TC,Nakanuma Y,Zen Y,Chen MF,Jan YY,Yeh TS,Chiu CT,Kuo TT,Kamiya J,Oda K,Hamaguchi M,Ohno Y,Hsieh LL,Nimura Y.Intraductal papillary neoplasia of the liver associated with hepatolithiasis.Hepatology 2001;34:651-658
  • 9[9]Ponsioen CI,Tytgat GN.Primary sclerosing cholangitis:A clinical review.Am J Gastroenterol 1998; 93:515-523
  • 10[10]Harrison PM.Prevention of bile duct cancer in primary sclerosing cholangitis.Ann Oncol 1999; 10(Suppl 4):S208-S211

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部